Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Douce

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Infection and Immunity|March 1, 1996
Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvantA Di Tommaso, G Saletti, M Pizza, et al.
Infection and Immunity|December 1, 1996
Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter rodentium eaeA mutant: induction of an immunoglobulin A response to intimin and EspBG Frankel, A D Phillips, M Novakova, et al.
Infection and Immunity|June 1, 1995
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteinsM Roberts, A Bacon, R Rappuoli, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 16, 2014
Cytological follow-up after hysterectomy: is vaginal vault cytology sampling a clinical governance problem? The University Hospital of North Staffordshire approachW Parry-Smith, D Thorpe, L Ogboro-Okor, et al.
Vaccine|March 21, 2001
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvantsM Pizza, M M Giuliani, M R Fontana, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 19, 2010
Implementing the national invasive cervical cancer audit: a local perspectiveE L Moss, P Pearmain, S Askew, et al.
Vaccine|June 2, 1998
Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvantM Marchetti, M Rossi, V Giannelli, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Infection and Immunity|March 1, 1996
Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvantA Di Tommaso, G Saletti, M Pizza, et al.
Infection and Immunity|December 1, 1996
Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter rodentium eaeA mutant: induction of an immunoglobulin A response to intimin and EspBG Frankel, A D Phillips, M Novakova, et al.
Infection and Immunity|June 1, 1995
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteinsM Roberts, A Bacon, R Rappuoli, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 16, 2014
Cytological follow-up after hysterectomy: is vaginal vault cytology sampling a clinical governance problem? The University Hospital of North Staffordshire approachW Parry-Smith, D Thorpe, L Ogboro-Okor, et al.
Vaccine|March 21, 2001
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvantsM Pizza, M M Giuliani, M R Fontana, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 19, 2010
Implementing the national invasive cervical cancer audit: a local perspectiveE L Moss, P Pearmain, S Askew, et al.
Vaccine|June 2, 1998
Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvantM Marchetti, M Rossi, V Giannelli, et al.
Pageof 4